Principal Financial Group Inc Zentalis Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$10.83 - $16.49 $5,577 - $8,492	515 Added 3.46%	15,396 $242,000
Q4 2023 Feb 07, 2024	BUY	$9.84 - $20.13 $2,371 - $4,851	241 Added 1.65%	14,881 $225,000
Q3 2023 Nov 02, 2023	BUY	$19.63 - $28.29 $10,973 - $15,814	559 Added 3.97%	14,640 $293,000
Q2 2023 Aug 07, 2023	BUY	$17.41 - $30.05 $10,498 - $18,120	603 Added 4.47%	14,081 $397,000
Q1 2023 May 09, 2023	SELL	$16.14 - $24.94 $14,881 - $22,994	-922 Reduced 6.4%	13,478 $231,000
Q4 2022 Feb 09, 2023	BUY	$18.07 - $25.6 $45,337 - $64,230	2,509 Added 21.1%	14,400 $290,000
Q3 2022 Nov 09, 2022	BUY	$20.23 - $31.73 $20,452 - $32,079	1,011 Added 9.29%	11,891 $257,000
Q2 2022 Aug 10, 2022	SELL	$17.91 - $52.25 $17,587 - $51,309	-982 Reduced 8.28%	10,880 $306,000
Q1 2022 May 09, 2022	BUY	$41.58 - $80.89 $12,598 - $24,509	303 Added 2.62%	11,862 $547,000
Q4 2021 Feb 09, 2022	SELL	$66.92 - $84.79 $285,882 - $362,222	-4,272 Reduced 26.99%	11,559 $972,000
Q3 2021 Nov 09, 2021	BUY	$46.83 - $73.5 $53,386 - $83,790	1,140 Added 7.76%	15,831 $1.06 Million
Q2 2021 Aug 10, 2021	BUY	$37.41 - $62.25 $328,459 - $546,555	8,780 Added 148.54%	14,691 $781,000
Q1 2021 May 10, 2021	SELL	$35.69 - $52.72 $36,439 - $53,827	-1,021 Reduced 14.73%	5,911 $256,000
Q4 2020 Feb 08, 2021	BUY	$31.71 - $57.97 $219,813 - $401,848	6,932 New	6,932 $360,000

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.